Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation. 2010

Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba Science City, Ibaraki 305-8572, Japan.

Estrogen is a growth factor that stimulates cell proliferation. The effects of estrogen are mediated through the estrogen receptors, ERalpha and ERbeta, which function as ligand-induced transcription factors and belong to the nuclear receptor superfamily. On the other hand, TGF-beta acts as a cell growth inhibitor, and its signaling is transduced by Smads. Although a number of studies have been made on the cross-talk between estrogen/ERalpha and TGF-beta/Smad signaling, whose molecular mechanisms remain to be determined. Here, we show that ERalpha inhibits TGF-beta signaling by decreasing Smad protein levels. ERalpha-mediated reductions in Smad levels did not require the DNA binding ability of ERalpha, implying that ERalpha opposes the effects of TGF-beta via a novel non-genomic mechanism. Our analysis revealed that ERalpha formed a protein complex with Smad and the ubiquitin ligase Smurf, and enhanced Smad ubiquitination and subsequent degradation in an estrogen-dependent manner. Our observations provide new insight into the molecular mechanisms governing the non-genomic functions of ERalpha.

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
January 2006, Trends in cardiovascular medicine,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
November 2021, Journal of the Formosan Medical Association = Taiwan yi zhi,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
November 2004, Circulation research,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
December 2009, Reproductive biology and endocrinology : RB&E,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
January 2017, Frontiers in pharmacology,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
February 2010, The Journal of biological chemistry,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
November 2000, The Journal of biological chemistry,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
May 2023, Phytotherapy research : PTR,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
December 2003, The Journal of biological chemistry,
Ichiaki Ito, and Aki Hanyu, and Mitsutoshi Wayama, and Natsuka Goto, and Yoko Katsuno, and Shohei Kawasaki, and Yuka Nakajima, and Masashi Kajiro, and Yoko Komatsu, and Akiko Fujimura, and Ryuichi Hirota, and Akiko Murayama, and Keiji Kimura, and Takeshi Imamura, and Junn Yanagisawa
June 2001, The Journal of biological chemistry,
Copied contents to your clipboard!